Date published: 2025-9-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

TRIM46 Inhibitors

Regarding the chemical class TRIM46 Inhibitors, this class is characterized by a diverse range of compounds primarily targeting signaling pathways and cellular processes that are indirectly related to the function of TRIM46. The inhibitors listed are mainly small molecule compounds that target key enzymes in various signaling cascades such as PI3K, MEK, MAPK, mTOR, and AKT. These pathways are crucial in regulating cellular processes like growth, proliferation, and stress response, which are areas where TRIM46 might play a role. The inhibitors operate by modulating these pathways, thereby exerting an influence on the cellular environment that affects the activity or expression of TRIM46. For instance, PI3K and AKT inhibitors like LY 294002 and Wortmannin disrupt the PI3K-AKT signaling axis, a pathway that could be involved in processes where TRIM46 has a role. Similarly, inhibitors targeting the MAPK pathway, such as PD 98059 and U0126, might indirectly influence TRIM46 activity by altering the cellular response to extracellular signals that govern cell division, differentiation, and survival.

Each of these compounds has unique characteristics in terms of their selectivity and potency against their primary targets. Their effects on TRIM46, however, are consequential to their primary mode of action, which is to disrupt specific signaling pathways. It is through this disruption that they may exert an indirect influence on TRIM46. This approach of targeting related pathways offers a strategic method to modulate the activity of proteins like TRIM46, especially in the absence of direct inhibitors. The compounds listed represent a range of chemical structures and properties, reflecting the diversity of mechanisms through which they can interact with cellular signaling pathways.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

A PI3K inhibitor that may alter AKT signaling, potentially influencing proteins like TRIM46.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$39.00
$90.00
212
(2)

An MEK inhibitor, could disrupt ERK/MAPK signaling, indirectly affecting TRIM46 activity.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$88.00
$342.00
284
(5)

A p38 MAPK inhibitor, might modulate stress-related pathways impacting TRIM46.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$65.00
$267.00
257
(3)

JNK inhibitor, could alter cellular stress responses, potentially affecting TRIM46.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Another PI3K inhibitor, may indirectly influence TRIM46 via AKT pathway modulation.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, could affect cellular growth pathways that interact with TRIM46.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$63.00
$241.00
136
(2)

An inhibitor of MEK1/2, potentially influencing ERK/MAPK pathways linked to TRIM46.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

ROCK inhibitor, might affect cytoskeletal dynamics, indirectly influencing TRIM46.

Triciribine

35943-35-2sc-200661
sc-200661A
1 mg
5 mg
$102.00
$138.00
14
(1)

AKT inhibitor, could modulate signaling pathways involving TRIM46.

AZD8055

1009298-09-2sc-364424
sc-364424A
10 mg
50 mg
$160.00
$345.00
12
(2)

mTOR inhibitor, might indirectly affect TRIM46 through cellular growth control pathways.